Pistacho and Sleep Quality
PistaSleep
Effect of Pistachio (Pistacia Vera L.) Consumption on Locomotor Activity and Molecular Regulation of the Circadian Clock in Adipose Tissue of Overweight Adults
1 other identifier
interventional
28
1 country
1
Brief Summary
The goal of this study is to evaluate the effect of pistachio (Pistacia vera L.) consumption on plasma melatonin, antioxidant capacity, and circadian rhythms in overweight young adults. The main question it aims to answer are:
- Can the consumption of pistachios, specifically their content of compounds like phyto-melatonin, effectively regulate the human biological clock and circadian rhythms?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedJune 16, 2026
June 1, 2026
13 days
June 1, 2026
June 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Body composition analysis
Body composition analysis (BCA, including fat mass \[FM\] and fat-free mass \[FFM\], in kg and %) was performed with a seca mBCA 514/515 medical Body Composition Analyzer (Allers Hamburg, Germany). The measurements were conducted in accordance with the guidelines of the International Society for the Advancement of Kinanthropometry (ISAK).
Baseline, 2 weeks, 4 weeks
Waist circumference
Waist circumference (WC, in cm) was measured using an ergonomic SECA 201 measuring tape.
Baseline, 2 weeks, 4 weeks
Plasma melatonin
Plasma obtained from the same samples of biochemicals determinations. Plasma melatonin levels were measured before and after the intervention using a commercial plasma melatonin kit.
Baseline, 2 weeks, 4 weeks
Circadian locomotor activity
A temperature sensor on the wirst, an activity and body position sensor was placed on the participant's arm and a luxometer was worn on the neck with a pendant over the clothing.
Through study completion during 28-days.
Questionnaire of activity during the day
Horne and Östberg morning- evening test. Visual Analog Score with a cumulative score scale
Baseline, 2 weeks, 4 weeks
Physical activity questionnaire (IPAQ)
Measured with the scale MET-minutes per week" (o MET-min/week)
Baseline, 2 weeks, 4 weeks
Pittsburgh Sleep Quality Index (PSQI)
Cumulative score scale by Gobal PSQI score
Baseline, 2 weeks, 4 weeks
Secondary Outcomes (3)
Concentration of metabolic and lipid parameters
Baseline, 2 weeks, 4 weeks
Plasma antioxidant activity by FRAP method
Baseline, 2 weeks, 4 weeks
Plasma antioxidant activity by ORAC assay.
Baseline, 2 weeks, 4 weeks
Study Arms (1)
Pistacho consumption
EXPERIMENTALParticipants consumed 28 g (equivalent to 5.6 mg of phytomelatonin) of pistachios each day, specifically 40 pistachios with shells, 1 hour to 30 minutes before bedtime.
Interventions
Participants consumed 28 g (equivalent to 5.6 mg of phyto-melatonin) of pistachios each day, specifically 40 pistachios with shells, 1 hour to 30 minutes before bedtime
Eligibility Criteria
You may qualify if:
- No diagnosed diseases
- Not regularly taking medications that affect melatonin synthesis or body regulation.
You may not qualify if:
- Smokers
- Pregnant women
- Individuals with night shifts, those following special diets or taking weight loss supplements
- People who had undergone recent surgical procedures or significant weight loss in two months before the study.
- Those taking sleep medications.
- Individuals who had made trans meridian trips within 1 month of the evaluation,
- Individuals with allergies, intolerances, or aversions to nuts/pistachios
- Participants who voluntarily withdrew from the study
- Participants who tested positive for COVID-19 during the intervention
- Participants who experienced adverse effects.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Autónoma de Querétaro
Querétaro City, Querétaro, 76000, Mexico
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full-time research professor.
Study Record Dates
First Submitted
June 1, 2026
First Posted
June 16, 2026
Study Start
September 13, 2021
Primary Completion
September 26, 2021
Study Completion
November 1, 2021
Last Updated
June 16, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share